Abstract
New recommendations on the management of pediatric emergencies and resuscitation were published by the American Heart Association. They now include recommendations for the use of high-dose epinephrine for cardiac arrest after one unsuccessful standard dose. Adenosine is now the drug of choice for pharmacologic conversion of supraventricular tachycardia. Noninvasive monitoring of the patient is emphasized. This article highlights the most important changes in pediatric resuscitation recommendations and explores the uses of high-dose epinephrine, adenosine, and end-tidal carbon dioxide monitoring.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
